Additional PET/CT in week 5-6 of radiotherapy for patients with stage III non-small cell lung cancer as a means of dose escalation planning?

Radiotherapy and Oncology

Volumn 88, Issue 3, 2008, Pages 335-341

  Gillham, Charles ^a,b   Zips, Daniel ^a,b   Pönisch, Falk ^a,b   Evers, Carsten ^a,b   Enghardt, Wolfgang ^a,b   Abolmaali, Nasreddin ^a,b   Zöphel, Klaus ^a,b   Appold, Steffen ^a,b   Hölscher, Tobias ^a,b   Steinbach, Jörg ^a,c   Kotzerke, Jörg ^a,b,c   Herrmann, Thomas ^a,b   Baumann, Michael ^a,b  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^c INSTITUTE OF ION BEAM PHYSICS AND MATERIALS RESEARCH   (Germany)

Author keywords

Adaptive targeting; Dose escalation; Lung cancer; PET CT; Radiotherapy

Indexed keywords

FLUORODEOXYGLUCOSE;

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER STAGING; CLINICAL ARTICLE; CLINICAL EVALUATION; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; HUMAN; INTERMETHOD COMPARISON; LUNG NON SMALL CELL CANCER; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION DOSE DISTRIBUTION; TREATMENT PLANNING; TUMOR VOLUME;

AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; DOSE FRACTIONATION; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 52049105882     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2008.05.004     Document Type: Article

References (49)

1. Saunders M., Dische S., Barrett A., et al. Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trial. CHART Steering committee. Radiother Oncol 52 (1999) 137-148
2. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. Non-small Cell Lung Cancer Collaborative Group. BMJ 1995;311:899-909.
3. Baumann M., Appold S., Petersen C., Zips D., and Herrmann T. Dose and fractionation concepts in the primary radiotherapy of non-small cell lung cancer. Lung Cancer 33 Suppl 1 (2001) S35-S45
4. Baumann M., Krause M., Zips D., et al. Molecular targeting in radiotherapy of lung cancer. Lung Cancer 45 Suppl 2 (2004) S187-S197
5. Rengan R., Rosenzweig K.E., Venkatraman E., et al. Improved local control with higher doses of radiation in large-volume stage III non-small cell lung cancer. Int J Radiat Oncol Biol Phys 60 (2004) 741-747
6. Willner J., Baier K., Caragiani E., Tschammler A., and Flentje M. Dose, volume, and tumor control prediction in primary radiotherapy of non-small cell lung cancer. Int J Radiat Oncol Biol Phys 52 (2002) 382-389
7. Hayman J.A., Martel M.K., Ten Haken R.K., et al. Dose escalation in non-small cell lung cancer using three-dimensional conformal radiation therapy: update of a phase I trial. J Clin Oncol 19 (2001) 127-136
8. Narayan S., Henning G.T., Ten Haken R.K., et al. Results following treatment to doses of 92.4 or 102.9 Gy on a phase I dose escalation study for non-small cell lung cancer. Lung Cancer 44 (2004) 79-88
9. Socinski M.A., Morris D.E., Halle J.S., et al. Induction and concurrent chemotherapy with high-dose thoracic conformal radiation therapy in unresectable stage IIIA and IIIB non-small cell lung cancer: a dose-escalation phase I trial. J Clin Oncol 22 (2004) 4341-4350
10. Rosenman J.G., Halle J.S., Socinski M.A., et al. High-dose conformal radiotherapy for treatment of stage IIIA/IIIB non-small cell lung cancer: technical issues and results of a phase I/II trial. Int J Radiat Oncol Biol Phys 54 (2002) 348-356
11. Bradley J., Graham M.V., Winter K., et al. Toxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small cell lung carcinoma. Int J Radiat Oncol Biol Phys 61 (2005) 318-328
12. Kong F.M., Ten Haken R.K., Schipper M.J., et al. High-dose radiation improved local tumor control and overall survival in patients with inoperable/unresectable non-small cell lung cancer: long-term results of a radiation dose escalation study. Int J Radiat Oncol Biol Phys 63 (2005) 324-333
13. Belderbos J.S., Heemsbergen W.D., De Jaeger K., Baas P., and Lebesque J.V. Final results of a Phase I/II dose escalation trial in non-small cell lung cancer using three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 66 (2006) 126-134
14. Thirion P., Holmberg O., Collins C.D., et al. Escalated dose for non-small cell lung cancer with accelerated hypofractionated three-dimensional conformal radiation therapy. Radiother Oncol 71 (2004) 163-166
15. De Ruysscher D., Wanders R., van Haren E., et al. HI-CHART: a Phase I/II study on the feasibility of high-dose continuous hyperfractionated accelerated radiotherapy in patients with inoperable non-small cell lung cancer. Int J Radiat Oncol Biol Phys (2007)
16. Miller K.L., Shafman T.D., Anscher M.S., et al. Bronchial stenosis: an underreported complication of high-dose external beam radiotherapy for lung cancer?. Int J Radiat Oncol Biol Phys 61 (2005) 64-69
17. De Ruysscher D., Wanders S., van Haren E., et al. Selective mediastinal node irradiation based on FDG-PET scan data in patients with non-small cell lung cancer: a prospective clinical study. Int J Radiat Oncol Biol Phys 62 (2005) 988-994
18. Rosenzweig K.E., Sura S., Jackson A., and Yorke E. Involved-field radiation therapy for inoperable non-small cell lung cancer. J Clin Oncol (2007)
19. De Ruysscher D., Wanders S., Minken A., et al. Effects of radiotherapy planning with a dedicated combined PET-CT-simulator of patients with non-small cell lung cancer on dose-limiting normal tissues and radiation dose-escalation: a planning study. Radiother Oncol 77 (2005) 5-10
20. Nestle U., Kremp S., and Grosu A.L. Practical integration of [18F]-FDG-PET and PET-CT in the planning of radiotherapy for non-small cell lung cancer (NSCLC): the technical basis, ICRU-target volumes, problems, perspectives. Radiother Oncol 81 (2006) 209-225
21. Lavrenkov K., Partridge M., Cook G., and Brada M. Positron emission tomography for target volume definition in the treatment of non-small cell lung cancer. Radiother Oncol 77 (2005) 1-4
22. Vanuytsel L.J., Vansteenkiste J.F., Stroobants S.G., et al. The impact of (18)F-fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) lymph node staging on the radiation treatment volumes in patients with non-small cell lung cancer. Radiother Oncol 55 (2000) 317-324
23. van Baardwijk A., Bosmans G., Boersma L., et al. PET-CT-based auto-contouring in non-small cell lung cancer correlates with pathology and reduces interobserver variability in the delineation of the primary tumor and involved nodal volumes. Int J Radiat Oncol Biol Phys 68 (2007) 771-778
24. Yom S.S., Liao Z., Liu H.H., et al. Initial evaluation of treatment-related pneumonitis in advanced-stage non-small cell lung cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 68 (2007) 94-102
25. Lavrenkov K., Christian J.A., Partridge M., et al. A potential to reduce pulmonary toxicity: the use of perfusion SPECT with IMRT for functional lung avoidance in radiotherapy of non-small cell lung cancer. Radiother Oncol 83 (2007) 156-162
26. Guckenberger M., Meyer J., Wilbert J., et al. Intra-fractional uncertainties in cone-beam CT-based image-guided radiotherapy (IGRT) of pulmonary tumors. Radiother Oncol 83 (2007) 57-64
27. Chang J.Y., Zhang X., Wang X., et al. Significant reduction of normal tissue dose by proton radiotherapy compared with three-dimensional conformal or intensity-modulated radiation therapy in stage I or stage III non-small cell lung cancer. Int J Radiat Oncol Biol Phys 65 (2006) 1087-1096
28. McDermott L.N., Wendling M., Sonke J.J., van Herk M., and Mijnheer B.J. Anatomy changes in radiotherapy detected using portal imaging. Radiother Oncol 79 (2006) 211-217
29. Bosmans G., van Baardwijk A., Dekker A., et al. Time trends in nodal volumes and motion during radiotherapy for patients with stage III Non-small cell lung cancer. Int J Radiat Oncol Biol Phys 71 (2008) 139-144
30. Britton K.R., Starkschall G., Tucker S.L., et al. Assessment of gross tumor volume regression and motion changes during radiotherapy for non-small cell lung cancer as measured by four-dimensional computed tomography. Int J Radiat Oncol Biol Phys 68 (2007) 1036-1046
31. Bosmans G., van Baardwijk A., Dekker A., et al. Intra-patient variability of tumor volume and tumor motion during conventionally fractionated radiotherapy for locally advanced non-small cell lung cancer: a prospective clinical study. Int J Radiat Oncol Biol Phys 66 (2006) 748-753
32. Kupelian P.A., Ramsey C., Meeks S.L., et al. Serial megavoltage CT imaging during external beam radiotherapy for non-small cell lung cancer: observations on tumor regression during treatment. Int J Radiat Oncol Biol Phys 63 (2005) 1024-1028
33. Erridge S.C., Seppenwoolde Y., Muller S.H., et al. Portal imaging to assess set-up errors, tumor motion and tumor shrinkage during conformal radiotherapy of non-small cell lung cancer. Radiother Oncol 66 (2003) 75-85
34. Siker M.L., Tome W.A., and Mehta M.P. Tumor volume changes on serial imaging with megavoltage CT for non-small cell lung cancer during intensity-modulated radiotherapy: how reliable, consistent, and meaningful is the effect?. Int J Radiat Oncol Biol Phys 66 (2006) 135-141
35. Underberg R.W., Lagerwaard F.J., van Tinteren H., et al. Time trends in target volumes for stage I non-small cell lung cancer after stereotactic radiotherapy. Int J Radiat Oncol Biol Phys 64 (2006) 1221-1228
36. Martel M.K., Ten Haken R.K., Hazuka M.B., et al. Estimation of tumor control probability model parameters from 3-D dose distributions of non-small cell lung cancer patients. Lung Cancer 24 (1999) 31-37
37. Seppenwoolde Y., Lebesque J.V., de Jaeger K., et al. Comparing different NTCP models that predict the incidence of radiation pneumonitis. Normal tissue complication probability. Int J Radiat Oncol Biol Phys 55 (2003) 724-735
38. Kwa S.L., Lebesque J.V., Theuws J.C., et al. Radiation pneumonitis as a function of mean lung dose: an analysis of pooled data of 540 patients. Int J Radiat Oncol Biol Phys 42 (1998) 1-9
39. Senan S., De Ruysscher D., Giraud P., Mirimanoff R., and Budach V. Literature-based recommendations for treatment planning and execution in high-dose radiotherapy for lung cancer. Radiother Oncol 71 (2004) 139-146
40. Kim T.H., Cho K.H., Pyo H.R., et al. Dose-volumetric parameters of acute esophageal toxicity in patients with lung cancer treated with three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 62 (2005) 995-1002
41. Emami B., Lyman J., Brown A., et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 21 (1991) 109-122
42. Grosu A.L., Piert M., Weber W.A., et al. Positron emission tomography for radiation treatment planning. Strahlenther Onkol 181 (2005) 483-499
43. Caldwell C.B., Mah K., Ung Y.C., et al. Observer variation in contouring gross tumor volume in patients with poorly defined non-small cell lung tumors on CT: the impact of 18FDG-hybrid PET fusion. Int J Radiat Oncol Biol Phys 51 (2001) 923-931
44. Fox J.L., Rengan R., O'Meara W., et al. Does registration of PET and planning CT images decrease interobserver and intraobserver variation in delineating tumor volumes for non-small cell lung cancer?. Int J Radiat Oncol Biol Phys 62 (2005) 70-75
45. Steenbakkers R.J., Duppen J.C., Fitton I., et al. Reduction of observer variation using matched CT-PET for lung cancer delineation: a three-dimensional analysis. Int J Radiat Oncol Biol Phys 64 (2006) 435-448
46. van Baardwijk A., Bosmans G., Dekker A., et al. Time trends in the maximal uptake of FDG on PET scan during thoracic radiotherapy. A prospective study in locally advanced non-small cell lung cancer (NSCLC) patients. Radiother Oncol 82 (2007) 145-152
47. Eschmann S.M., Friedel G., Paulsen F., et al. Repeat 18F-FDG PET for monitoring neoadjuvant chemotherapy in patients with stage III non-small cell lung cancer. Lung Cancer 55 (2007) 165-171
48. Madani I., Duthoy W., Derie C., et al. Positron emission tomography-guided, focal-dose escalation using intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 68 (2007) 126-135
49. Schütze C., Bergmann R., Yaromina A., et al. Effect of increase of radiation dose on local control relates to pre-treatment FDG-uptake in FaDu tumours in nude mice. Radiother Oncol 83 (2007) 311-315